Gerresheimer Stock Becomes Even More Attractive Through Inclusion in MDAX on December 22, 2008 On September 6, 2007 Gerresheimer was Already Included in the SDAX Ahead of the Normal Scheduling Process
DUSSELDORF, Germany, December 4 /PRNewswire-FirstCall/ -- Gerresheimer
stock will be included in the MDAX Index on December 22, 2008. This was
decided by the Management Board of the German Stock Exchange late on
Wednesday evening in the course of the review of the selection indices.
Gerresheimer AG has been listed in the Prime Standard of the Frankfurt
Stock Exchange since June 11, 2007 after one of the largest IPOs of the year,
with a total issue volume in excess of EUR900 million. Already, on September
6, 2007, Gerresheimer was included in the SDAX Index ahead of the normal
scheduling process.
"Inclusion in the index confirms Gerresheimer's outstanding development.
As an MDAX constituent our company is now even more attractive for national
as well as international investors and attracts the attention of the capital
market to an increased degree," says Dr. Axel Herberg, CEO of Gerresheimer AG.
In the first nine months of the financial year 2008 (December 2007 to
August 2008), sales increased markedly by 12.3 % to EUR783.4m (prior year
period: EUR697.4m). Operating results (adjusted EBITDA) to the end of August
actually improved by 18.1 % to EUR146.9m (EUR124.4m). The adjusted EBITDA
margin was 18.8 %, a full percentage point higher than in the comparable
period of the prior year.
About Gerresheimer
Gerresheimer employs more than 10,000 people in 40 locations in Europe,
America and Asia. In the financial year 2007, worldwide sales totalled
EUR958m. The product portfolio ranges from pharmaceutical vials made of glass
and plastic through to complex drug-delivery systems for the pharma & life
science industry. These include sterile syringes, inhalers and other
system-based approaches for safe dosage and application of medications. The
Group enjoys a leading position in markets which are characterised by high
technical and regulatory barriers.
Contact Press
Burkhard Lingenberg
Director Corporate PR & Marketing
Telephone +49-211-6181-250
Telefax +49-211-6181-241
E-mail b.lingenberg@gerresheimer.com
Contact Investor Relations
Anke Linnartz
Director Corporate Investor Relations
Telephone +49-211-6181-314
Telefax +49-211-6181-121
E-mail a.linnartz@gerresheimer.com
SOURCE Gerresheimer AG
